pLX302 Luciferase-V5 puro Citations (5)
Originally described in: Simultaneous profiling of 194 distinct receptor transcripts in human cells.Kang BH, Jensen KJ, Hatch JA, Janes KA Sci Signal. 2013 Aug 6;6(287):rs13. doi: 10.1126/scisignal.2003624. PubMed Journal
Articles Citing pLX302 Luciferase-V5 puro
| Articles |
|---|
Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.
Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA.
Dev Cell. 2017 Nov 20;43(4):418-435.e13. doi: 10.1016/j.devcel.2017.10.027.
PubMed
Associated Plasmids |
| Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Wang M, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Ferreira RB, Chiang CW, Guryanova OA, Kopinke D, Heldermon CD, Castellano RK, Law BK. Cell Death Discov. 2019 Dec 10;5:153. doi: 10.1038/s41420-019-0228-9. eCollection 2019. PubMed |
| EVI/WLS function is regulated by ubiquitylation and is linked to ER-associated degradation by ERLIN2. Wolf LM, Lambert AM, Haenlin J, Boutros M. J Cell Sci. 2021 Aug 15;134(16). pii: 271857. doi: 10.1242/jcs.257790. Epub 2021 Aug 18. PubMed |
| ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. Bopple K, Oren Y, Henry WS, Dong M, Weller S, Thiel J, Kleih M, Gaissler A, Zipperer D, Kopp HG, Aylon Y, Oren M, Essmann F, Liang C, Aulitzky WE. Cell Death Dis. 2024 Apr 24;15(4):290. doi: 10.1038/s41419-024-06674-x. PubMed |
| TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice. Chen KZ, Lin ZY, Chen LJ, Zhou YX, Zhang W, Wan HY, Huo YK, Fu Q, Gao ZQ, Cheng HW, Ma XD, Zhang SS. Mil Med Res. 2025 Nov 11;12(1):78. doi: 10.1186/s40779-025-00667-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.